首页> 外文期刊>Cellular immunology >Lysophosphatidic acid enhances antimycobacterial response during in vivo primary Mycobacterium tuberculosis infection.
【24h】

Lysophosphatidic acid enhances antimycobacterial response during in vivo primary Mycobacterium tuberculosis infection.

机译:溶血磷脂酸可增强体内原发性结核分枝杆菌感染过程中的抗分枝杆菌反应。

获取原文
获取原文并翻译 | 示例
       

摘要

Lysophospholipids may play an important protective role during primary infection of Mycobacterium tuberculosis (MTB) by enhancing innate antimycobacterial immune response of both macrophages and alveolar epithelial cells. Here, we show that treatment with lysophosphatidic acid (LPA) of mice aerogenically infected with MTB immediately after infection results in a significant early reduction of pulmonary CFUs and of histopathological damage in comparison with control mice. In contrast, treatment of acute disease does not result in any improvement of both microbiological and histopathological parameters. Altogether, these results show that LPA treatment can exert protective effect if administrated during primary infection, only.
机译:溶血磷脂可能通过增强巨噬细胞和肺泡上皮细胞的固有抗分枝杆菌免疫应答而在结核分枝杆菌(MTB)的初次感染中发挥重要的保护作用。在这里,我们显示,与对照小鼠相比,感染后立即用MTB气生性感染MTB的小鼠用溶血磷脂酸(LPA)处理可导致肺CFU的早期显着减少和组织病理学损害。相反,急性疾病的治疗不会导致微生物学和组织病理学参数的任何改善。总而言之,这些结果表明,仅在原发感染期间施用LPA治疗才能发挥保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号